News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
825,982 Results
Type
Article (85329)
Company Profile (694)
Press Release (739959)
Section
Business (231822)
Career Advice (4099)
Deals (39634)
Drug Delivery (112)
Drug Development (90505)
Employer Resources (194)
FDA (17899)
Job Trends (17258)
News (394802)
Policy (39578)
Tag
Academia (2972)
Alliances (56337)
Alzheimer's disease (1293)
Approvals (17828)
Artificial intelligence (112)
Bankruptcy (394)
Best Places to Work (12354)
Biosimilars (81)
Biotechnology (477)
Breast cancer (85)
Cancer (804)
Career advice (3507)
Cell therapy (207)
Clinical research (70889)
Collaboration (292)
Compensation (131)
COVID-19 (2775)
Cystic fibrosis (79)
Data (704)
Diabetes (95)
Diagnostics (6557)
Earnings (93427)
Employer resources (166)
Events (125465)
Executive appointments (204)
FDA (18216)
Featured Employer (79)
Funding (242)
Gene therapy (158)
GLP-1 (615)
Government (5013)
Healthcare (20611)
Infectious disease (2830)
Inflammatory bowel disease (112)
Interviews (806)
IPO (17505)
Job creations (5176)
Job search strategy (2853)
Layoffs (477)
Legal (10010)
Lung cancer (138)
Manufacturing (149)
Medical device (14230)
Medtech (14235)
Mergers & acquisitions (21994)
Metabolic disorders (322)
Neuroscience (1514)
NextGen Class of 2024 (7639)
Non-profit (5046)
Northern California (1021)
Obesity (186)
Opinion (240)
Patents (87)
People (63855)
Pharmaceutical (135)
Phase I (21811)
Phase II (30786)
Phase III (23233)
Pipeline (171)
Podcasts (85)
Postmarket research (3533)
Preclinical (9860)
Radiopharmaceuticals (241)
Rare diseases (174)
Real estate (7366)
Regulatory (25711)
Research institute (2635)
Resumes & cover letters (647)
Southern California (941)
Startups (4271)
United States (10461)
Vaccines (595)
Weight loss (163)
Date
Today (154)
Last 7 days (653)
Last 30 days (2369)
Last 365 days (36255)
2024 (29649)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37192)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1261)
Arizona (210)
Asia (49082)
Australia (8654)
California (2399)
Canada (963)
China (187)
Connecticut (94)
Europe (112324)
Florida (286)
Illinois (307)
Indiana (167)
Kansas (102)
Maryland (506)
Massachusetts (2077)
Michigan (133)
Minnesota (225)
New Jersey (728)
New York (716)
North Carolina (740)
Northern California (1021)
Ohio (108)
Pennsylvania (628)
South America (1646)
Southern California (941)
Texas (306)
Washington State (309)
825,982 Results for "landmark bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming Technology
October 16, 2024
·
6 min read
Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study and its own, recently published, bioequivalence study
Crossject provides additional, clinically meaningful perspectives on ZEPIZURE® in light of its recently published bioequivalence study results and of the conclusions and hints by the authors of the RAMPART study1, a landmark double-blind randomized clinical trial comparing the efficacy of IM midazolam vs. IV lorazepam in the pre-hospital treatment of status epilepticus by paramedics.
June 26, 2024
·
5 min read
Press Releases
Texas Biomedical Research Institute enters landmark partnership with Coalition for Epidemic Preparedness Innovations
October 29, 2024
·
3 min read
Business
Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos’ Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care
Landmark Bio announced that it has signed a multi-year strategic manufacturing agreement with Galapagos NV (Euronext & NASDAQ: GLPG), an innovative biotech company with operations in Europe and the U.S.
November 6, 2023
·
3 min read
Press Releases
Caris Life Sciences and ECOG-ACRIN Partner to Interrogate Landmark TAILORx Breast Cancer Trial
October 24, 2024
·
7 min read
Press Releases
K2 Medical Research, The Villages Achieves Landmark Milestone in Alzheimer’s Research
October 28, 2024
·
2 min read
Biotech Beach
Vividion Therapeutics and Roche Jointly Publish Landmark Nature Paper on Clinical-Stage Covalent Allosteric Inhibitor of Werner Helicase (WRN)
Vividion Therapeutics, Inc. today announced a landmark publication in Nature.
April 25, 2024
·
4 min read
Press Releases
Twelve-Month Results from Landmark QUEST Study Published in Neuromodulation
September 27, 2024
·
5 min read
Press Releases
Nexalin Technology Announces Landmark Study on Alzheimer’s Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer’s Disease
October 29, 2024
·
7 min read
Biotech Beach
Landmark Study of a Revolutionary Device for the Treatment of Post Amputation Pain Accepted for Publication in the Journal of Pain Research
Neuros Medical, Inc. announced acceptance for publication of the 3-month results from the landmark QUEST Study demonstrating treatment with the Altius® Direct Electrical Nerve Stimulation System results in immediate and lasting pain reduction, decreased opioid use, and improved quality of life in patients suffering with chronic post-amputation pain.
May 22, 2024
·
4 min read
1 of 82,599
Next
